Amcor to expand healthcare packaging capabilities in Europe
Amcor (NYSE: AMCR) has announced a multi-million-dollar investment to enhance its healthcare packaging facility in Sligo, Ireland, by adding new thermoforming capabilities. This initiative aims to strengthen Amcor's position in the burgeoning sterile packaging market, which is projected to grow at over 4% annually, reaching $171 billion in Europe by 2027. The upgraded facility will feature Class 7 cleanroom environments and ISO 13485 certification, ensuring compliance with top industry standards. This investment follows a similar initiative in Singapore, positioning Amcor to meet increasing global demands in the medical and pharmaceutical sectors.
- Multi-million-dollar investment to enhance healthcare packaging capabilities.
- Strengthened leadership position in the growing sterile packaging market.
- Projected growth of European medical device segment to $171 billion by 2027.
- New facility features Class 7 cleanroom environments certified to ISO 13485 standards.
- None.
ZURICH, April 25, 2022 /PRNewswire/ -- Amcor (NYSE: AMCR) (ASX: AMC), a global leader in developing and producing responsible packaging solutions, today announced an investment to establish new thermoforming capabilities for medical packaging in its Sligo, Ireland, healthcare packaging facility. The multi-million-dollar investment will strengthen Amcor's leadership in the growing industry for sterile packaging, offering customers in Europe and North America another site with comprehensive healthcare solutions.
"The additional capabilities in our Sligo site allow us to provide customers with even more differentiated and efficient solutions to meet their healthcare packaging needs," said Amcor's Chief Commercial Officer Peter Konieczny. "With our global scale and innovation capabilities, Amcor is uniquely positioned to capture growing demand for both medical and pharmaceutical packaging products globally."
Through this investment, the Sligo site will feature Class 7 cleanroom manufacturing environments and state-of-the art thermoforming operations, fully certified to ISO 13485 standards and meeting the highest regulatory requirements. Amcor will also create a full design studio to support product development, enabling customers to tap into local and global expertise and resources across the company's growing network of global innovation centers.
According to Market Data Forecast, the European medical device segment, which relies on this type of packaging, is expected to grow at annual rate of more than
About Amcor Amcor is a global leader in developing and producing responsible packaging for food, beverage, pharmaceutical, medical, home- and personal-care, and other products. Amcor works with leading companies around the world to protect their products and the people who rely on them, differentiate brands, and improve supply chains through a range of flexible and rigid packaging, specialty cartons, closures, and services. The company is focused on making packaging that is increasingly light-weighted, recyclable and reusable, and made using an increasing amount of recycled content. Around 46,000 Amcor people generate US
www.amcor.com I LinkedIn I Facebook I Twitter I YouTube
View original content:https://www.prnewswire.com/news-releases/amcor-to-expand-healthcare-packaging-capabilities-in-europe-301530494.html
SOURCE Amcor
FAQ
What investment has Amcor announced for its Sligo facility?
How will the new capabilities in Sligo affect Amcor's market position?
What regulatory standards will the new facility in Sligo meet?
What is the expected growth of the European medical device market?
What recent developments have occurred alongside the Sligo investment?
